TY - JOUR
T1 - Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI
AU - Yan, Tianyi
AU - Wang, Yonghao
AU - Weng, Zizheng
AU - Du, Wenying
AU - Liu, Tiantian
AU - Chen, Duanduan
AU - Li, Xuesong
AU - Wu, Jinglong
AU - Han, Ying
N1 - Funding Information:
We gratefully acknowledge all the participants, clinical doctors and researchers at the Department of Neurology, XuanWu Hospital of Capital Medical University. This work was supported by the National Key R&D Program of China (grant number 2018YFC0115400, 2016YFC1306300); the National Natural Science Foundation of China (grant numbers 81671776, 61727807, 61633018); the Beijing Municipal Science & Technology Commission (grant numbers Z161100002616020, Z181100003118007, Z191100010618004), the Beijing Nova Program The supplementary material the electronic version of this doi.org/10.3233/JAD-181049.
Publisher Copyright:
© 2019 - IOS Press and the authors. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Alzheimer's disease (AD) is one of the most common progressive and irreversible neurodegenerative diseases. The study of the pathological mechanism of AD and early-stage diagnosis is essential and important. Subjective cognitive decline (SCD), the first at-risk stage of AD occurring prior to amnestic mild cognitive impairment (aMCI), is of great research value and has gained our interest. To investigate the entire pathological development of AD pathology efficiently, we proposed a machine learning classification method based on a multimodal support vector machine (SVM) to investigate the structural and functional connectivity patterns of the three stages of AD (SCD, aMCI, and AD). Our experiments achieved an accuracy of 98.58% in the AD group, 97.76% in the aMCI group, and 80.24% in the SCD group. Moreover, in our experiments, we identified the most discriminating brain regions, which were mainly located in the default mode network and subcortical structures (SCS). Notably, with the development of AD pathology, SCS regions have become increasingly important, and structural connectivity has shown more discriminative power than functional connectivity. The current study may shed new light on the pathological mechanism of AD and suggests that whole-brain connectivity may provide potential effective biomarkers for the early-stage diagnosis of AD.
AB - Alzheimer's disease (AD) is one of the most common progressive and irreversible neurodegenerative diseases. The study of the pathological mechanism of AD and early-stage diagnosis is essential and important. Subjective cognitive decline (SCD), the first at-risk stage of AD occurring prior to amnestic mild cognitive impairment (aMCI), is of great research value and has gained our interest. To investigate the entire pathological development of AD pathology efficiently, we proposed a machine learning classification method based on a multimodal support vector machine (SVM) to investigate the structural and functional connectivity patterns of the three stages of AD (SCD, aMCI, and AD). Our experiments achieved an accuracy of 98.58% in the AD group, 97.76% in the aMCI group, and 80.24% in the SCD group. Moreover, in our experiments, we identified the most discriminating brain regions, which were mainly located in the default mode network and subcortical structures (SCS). Notably, with the development of AD pathology, SCS regions have become increasingly important, and structural connectivity has shown more discriminative power than functional connectivity. The current study may shed new light on the pathological mechanism of AD and suggests that whole-brain connectivity may provide potential effective biomarkers for the early-stage diagnosis of AD.
KW - Alzheimer's disease
KW - diffusion tensor imaging
KW - machine learning
KW - multimodal MRI
KW - resting-state fMRI
UR - http://www.scopus.com/inward/record.url?scp=85064388045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064388045&partnerID=8YFLogxK
U2 - 10.3233/JAD-181049
DO - 10.3233/JAD-181049
M3 - Article
C2 - 30958352
AN - SCOPUS:85064388045
SN - 1387-2877
VL - 68
SP - 1013
EP - 1027
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - 3
ER -